Dr. Robert W Decker M.D.
Hematologist-Oncologist | Hematology & Oncology
9090 Wilshire Blvd Suite 200 Beverly Hills CA, 90211About
Dr. Robert Decker is a hematologist oncologist practicing in Beverly Hills, CA. Dr. Decker specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ Of Ca- Davis- Sch Of Med- Davis Ca 1981
University of California 1981
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Is buyer forced to accept low bid?
- Reductions of nitro and 9-Oxo groups of environmental nitrofluorenes by the rat mammary gland in vitro.
- Effects of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347), an alkylating agent derived from 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
- Binding of daunomycin to DNA and the inhibition of RNA and DNA synthesis.
- Activation of the carcinogen N-hydroxy-N-(2-fluorenyl)benzamide via chemical and enzymatic oxidations. Comparison to oxidations of the structural analogue N-hydroxy-N-(2-fluorenyl)acetamide.
- Volcanism in Mexico and central america.
- Sex hormone-mediated effects on the phase I and phase II metabolism of N-2-fluorenylacetamide. Modulation of 9-hydroxylation.
- Modifications of hepatic microsomal 9-oxidation of N-2-fluorenylacetamide in response to gonadectomy and treatment of rats with phenobarbital or diethylnitrosamine.
- Metabolite profile in milk of lactating rats after treatment with a carcinogen, N-2-fluorenylacetamide.
- Peroxidative metabolism of a carcinogen, N-hydroxy-N-2-fluorenylacetamide, by rat uterus and mammary gland in vitro.
- Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
- Modifications of carcinogen metabolism in hepatic microsomes of suckling young by 3-methylcholanthrene or beta-naphthoflavone administered to lactating rats.
- Incorporation of tritium-labeled thymidine monophosphate into nuclear DNA by permeabilized yeast cells.
- Alteration of DNA by 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347).
Treatments
- Anemia
- Breast Cancer
- Colon Cancer
- Lymphoma
- Extra Corporeal Shockwave Therapy
Dr. Robert W Decker M.D.'s Practice location
Dr. Robert W Decker M.D.'s reviews
Write ReviewRecommended Articles
- Facts About Multiple Myeloma
Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
- Living with Lymphoma Day by Day
A majority of individuals diagnosed with lymphoma find that they have to make a great deal of adjustments to their lives. There are several physical, emotional, social, and everyday obstacles from diagnosis to remission.Living with lymphoma can be different for every individual, which is why it is...
- New Study Discovers How Lymphoma Affects Survivors’ Ability to Work
Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...
- 'Robocop' Stem Cells Developed to Fight Cancer
Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
- Little Boy Tugs at Heartstrings of Entire Community: Be the Match!
Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...
Nearby Providers
- Dr. Nader Javadi M.D.8900 Wilshire Blvd Beverly Hills CA 90211
- Dr. Barry Rosenbloom M.D.9090 Wilshire Blvd Beverly Hills CA 90211
- Dr. Afshin Eli Gabayan M.D.8900 Wilshire Blvd Beverly Hills CA 90211
- Dr. Solomon Hamburg M.D.9090 Wilshire Blvd Beverly Hills CA 90211
- Dr. Philomena F. Mcandrew M.D.9090 Wilshire Blvd Beverly Hills CA 90211
- David Berz MD, PHD, MPH8900 WILSHIRE BLVD BEVERLY HILLS CA 90211